FPC
CORT icon

Falcon Point Capital’s Corcept Therapeutics CORT Stock Holding History

Falcon Point Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-31,620
Closed -$230K – 119
2016
Q4 		$230K Sell
31,620
-82,659
-72% -$648K 0.03% 104
2016
Q3 		$793K Buy
114,279
+17,704
+18% +$103K 0.12% 78
2016
Q2 		$527K Buy
96,575
+10,569
+12% +$55K 0.09% 87
2016
Q1 		$403K Buy
86,006
+9,604
+13% +$37.4K 0.07% 94
2015
Q4 		$380K Buy
76,402
+5,096
+7% +$23K 0.08% 94
2015
Q3 		$268K Buy
+71,306
New +$362K 0.1% 110

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return